Early pregnancy loss treatment

Early pregnancy loss (EPL) is defined as a nonviable, intrauterine pregnancy within the first trimester (either anembryonic pregnancy or embryonic death). Unfortunately, it is common in the general population, and even more prevalent among sub-fertile women undergoing fertility treatments.

Misoprostol (Cytotec) is an accepted treatment for EPL worldwide. Despite its widespread use, there is no consensus regarding the optimal treatment protocol, and the common practice differs greatly between clinics.

In order to improve our everyday practice, and to highlight the controversies in misoprostol treatment, we would be thankful if you could answer a few questions regarding your preferences for the treatment of EPL. We know that your time is scarce, and this survey should take less than 5 minutes.

The personal data requested aims only to assure the safety and authenticity of the data submitted. No personal data will be published